Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
Open Access
- 27 February 2025
- journal article
- correction
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 60 (5) , 746